Data availability
The study data will be made available upon a written reasoned request to the corresponding author.
References
Casella M, Dello Russo A, Russo E, Al-Mohani G, Santangeli P, Riva S, et al. Biomarkers of myocardial injury with different energy sources for atrial fibrillation catheter ablation. Cardiol J. 2014;21(5):516–23.
Yano M, Egami Y, Yanagawa K, Nakamura H, Matsuhiro Y, Yasumoto K, et al. Comparison of myocardial injury and inflammation after pulmonary vein isolation for paroxysmal atrial fibrillation between radiofrequency catheter ablation and cryoballoon ablation. J Cardiovasc Electrophysiol. 2020;31(6):1315–22.
Füting A, Reinsch N, Höwel D, Brokkaar L, Rahe G, Neven K. First experience with pulsed field ablation as routine treatment for paroxysmal atrial fibrillation. Europace. 2022;24(7):1084–92.
My I, Lemoine MD, Butt M, Mencke C, Loeck FW, Obergassel J, et al. Acute lesion extension following pulmonary vein isolation with two novel single shot devices: pulsed field ablation versus multielectrode radiofrequency balloon. J Cardiovasc Electrophysiol. 2023;34(9):1802–7.
Sairaku A, Morishima N, Matsumura H, Amioka M, Maeda J, Watanabe Y, et al. Intra-procedural anticoagulation and post-procedural hemoglobin fall in atrial fibrillation ablation with minimally interrupted direct oral anticoagulants: comparisons across 4 drugs. J Interv Card Electrophysiol. 2021;61(3):551–7.
Blockhaus C, Guelker JE, Feyen L, Bufe A, Seyfarth M, Shin DI. Pulsed field ablation for pulmonary vein isolation: real-world experience and characterization of the antral lesion size compared with cryoballoon ablation. J Interv Card Electrophysiol. 2023;66(3):567–75.
Reiner Z, Catapano AL, De Backer G, Graham I, Taskinen MR, Wiklund O, Agewall S, Alegria E, Chapman MJ, Durrington P, Erdine S, Halcox J, Hobbs R, Kjekshus J, Filardi PP, Riccardi G, Storey RF, Wood D; ESC Committee for Practice Guidelines (CPG) 2008–2010 and 2010–2012 Committees. ESC/EAS Guidelines for the management of dyslipidaemias: the Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS). Eur Heart J. 2011;32(14):1769–818.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
M. Malacrida is an employee of Boston Scientific. The other authors have no conflicts of interest to declare that are relevant to the content of this article.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Casella, M., Compagnucci, P., Malacrida, M. et al. Pulsed-field ablation of atrial fibrillation: kinetics of release of multiple cardiac biomarkers. J Interv Card Electrophysiol (2024). https://doi.org/10.1007/s10840-023-01733-3
Received:
Accepted:
Published:
DOI: https://doi.org/10.1007/s10840-023-01733-3